Nov 11, 2010 12:00 pm EST SCYNEXIS Receives Four Grants Under Federal Therapeutic Discovery Project Program
Nov 10, 2010 8:30 am EST SCYNEXIS Introduces Application for Mobile Access to HEOS Information System
Sep 14, 2010 8:52 am EDT SCYNEXIS Announces Presentations of Data From Anti-Fungal Drug Candidate at the 50th ICAAC Meeting
May 19, 2010 8:08 am EDT SCYNEXIS and Trevena Announce Strategic Collaboration to Enhance Discovery of Biased GPCR Ligands
Apr 16, 2010 9:35 am EDT SCYNEXIS Presents In Vitro Toxicity Study Suggesting that SCY-635 is Unique in the Cyclophilin Inhibitor Class
Apr 15, 2010 12:01 pm EDT SCYNEXIS' SCY-635 Demonstrates Impressive Barrier to Resistance in HCV Treatment
Apr 5, 2010 9:35 am EDT SCYNEXIS Announces Acceptance of Abstracts Related to its Hepatitis C Clinical Candidate, SCY-635, for Presentation at 45th Annual Meeting of the European Association for the Study of the Liver
